Biological nanoparticle analysis requires a structured approach, especially when samples involve extracellular vesicles, exosomes, viral vectors or other complex particles. Choosing an analyzer does not only depend on the technology promoted by the manufacturer, but above all on the parameters that are actually needed: size, concentration, charge, fluorescence, available volume, analysis throughput and level of automation.
To select the right solution, laboratories need to start from the constraints of the sample rather than from the instrument specifications alone. One platform may be relevant for fast process monitoring, while another may be better suited to detailed characterization of subpopulations.
Define the requirements before comparing instruments
Before comparing available technologies, it is essential to clarify the type of data required. Not all particle analyzers meet the same objectives. Some systems only provide a size distribution, while others allow single-particle counting, concentration measurement or additional information such as zeta potential or fluorescence.
For biological samples, this distinction is important. Particle populations are often heterogeneous, with similar size ranges, variable concentrations and sometimes specific subpopulations of interest. A technology that performs well on reference beads will not necessarily provide the same level of performance on extracellular vesicles or viral vectors.
The first question is therefore the purpose of the analysis: is the goal to size a population, quantify a concentration, identify a subpopulation or monitor changes during a process? This clarification already helps eliminate methods that do not provide the required data.
Biological nanoparticle analysis : Consider the actual size of the particles to be analyzed
The size range is often the most decisive criterion. For biological nanoparticles, it is not enough to look at the lower limit stated by a manufacturer. This limit may depend on the material, the refractive index, the background noise level and the actual nature of the sample.
Optical methods can become more difficult to use when particles are very small or weakly scattering. This is why the choice should always be based on the critical population that needs to be measured. For example, an instrument may be suitable for some extracellular vesicles, but less appropriate for smaller particles or highly diluted samples.
Heterogeneity should also be considered. When several populations coexist in the same sample, the selected technology must be able to distinguish them with sufficient resolution. In some cases, a global analysis may hide an important subpopulation.
Compare the main available parameters
Biological nanoparticle characterization technologies can be compared according to several criteria: size, concentration, charge, fluorescence, analysis throughput, sample volume and ease of use.
| Platform | Principle | Available data | Main use |
| NanoSight – Malvern Panalytical | NTA | Size, concentration, fluorescence depending on configuration | Nanoparticle analysis and population monitoring |
| ZetaView – Particle Metrix | NTA | Size, concentration, zeta potential, fluorescence | Multiparametric analysis and subpopulations |
| Exoid – Izon | TRPS | Size, concentration, charge | High-resolution single-particle analysis |
| NanoAnalyzer – NanoFCM | Nano-flow cytometry | Size, concentration, biochemical properties, fluorescence | Phenotyping of biological particles |
| Virus Counter – Sartorius | Fluorescence-based counting | Viral counting | Targeted analysis of viral particles |
| Videodrop – Myriade Lab | ILM | Size and concentration | Fast counting and process monitoring |
This table is not intended to identify one instrument as better than the others. It is designed to narrow down the selection according to user needs. If charge measurement is essential, some platforms become more relevant. If the objective is to identify a labeled subpopulation, fluorescence becomes a central criterion. If throughput and simplicity are the priority, a fast solution may be more appropriate than a more complete but heavier instrument to operate.
Adapt the technology to the sample type
Extracellular vesicles, exosomes, viral vectors and biological nanoparticles do not present the same constraints. Their size, concentration, composition and behavior in suspension can vary significantly from one sample to another.
For extracellular vesicles, the main challenge often relates to heterogeneity and the ability to identify specific populations. For viral vectors, counting, concentration and the ability to work with complex matrices may become decisive. For fluorescent or labeled particles, it is important to check whether the instrument is compatible with the required channels and markers.
Available volume must also be taken into account. Some biological samples are valuable or produced in small quantities. A technology requiring only a small volume or allowing fast processing can then represent an important advantage.
Biological nanoparticle analysis : Evaluate daily use in the laboratory
A particle analyzer should be assessed under conditions close to real use. Theoretical performance is not enough if the instrument is too complex to prepare, too long to clean or too dependent on the operator.
It is useful to observe the full analysis time, from sample preparation to cleaning. Reproducibility between different users should also be checked. A clear and repeatable protocol is essential when several operators use the same instrument.
Weekly throughput also plays an important role. For occasional analyses, a highly detailed instrument may be suitable. For routine monitoring or large numbers of samples, ease of use, automation and measurement time become major criteria.
Organize a trial with representative samples
Before selecting a solution, it is preferable to request a trial using real laboratory samples. Standards or generic demonstrations do not always reflect the difficulties encountered with biological matrices.
The trial should include representative samples, but also the most complex ones: low concentrations, high heterogeneity, significant background noise or limited volume. This step helps assess the robustness of the technology and the quality of the results obtained.
During evaluation, several points should be observed:
- total preparation, acquisition and cleaning time;
- consistency of results between several operators;
- ability to process complex samples;
- sample volume consumed;
- ease of use of the software;
- parameters that are actually usable for the intended application.
This approach helps distinguish advertised performance from useful performance in a laboratory context.
Choose a solution according to analysis objectives
The choice of an analyzer should not be limited to the most complete technology. A platform must first meet the real needs of the laboratory. For some applications, the priority will be fast counting. For others, it will be resolution, charge measurement, fluorescence or subpopulation identification.
In some cases, combining two technologies may be relevant. A fast solution can be used for routine monitoring, while a more detailed instrument can be reserved for in-depth analyses or validation. This organization avoids using a complex system for simple and repetitive controls.
Biological nanoparticle analysis therefore depends on a balance between performance, simplicity, throughput and data relevance. By starting from the samples, expected parameters and routine constraints, it becomes easier to compare available technologies and select the most suitable instrument.
